HomeClinical TopicsFDA requires safety labeling changes for fluoroquinolones

FDA requires safety labeling changes for fluoroquinolones

Author(s):

On July 10, the U.S. Food and Drug Administration (FDA) announced safety labeling changes for fluoroquinolones, including stronger warnings about risks of mental health disturbances and hypoglycemic coma.

Read more via FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content